Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FRET sensors reveal the retinal entry pathway in the G protein-coupled receptor rhodopsin. | iScience | 2022 | 35355518 | PubTator, text mining | PubMed |
| Structural insights into thyrotropin-releasing hormone receptor activation by an endogenous peptide agonist or its orally administered analogue. | Cell Res | 2022 | 35352031 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screen reveals CLPTM1L as a lipid scramblase required for efficient glycosylphosphatidylinositol biosynthesis. | Proc Natl Acad Sci U S A | 2022 | 35344438 | PubTator, text mining | PubMed |
| [Targeted Therapy and Mechanism of Drug Resistance in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor Gene Mutation]. | Zhongguo Fei Ai Za Zhi | 2022 | 35340161 | PubTator, text mining | PubMed |
| TRK inhibitor activity and resistance in TRK fusion-positive cancers in adults. | Cancer Genet | 2022 | 35334340 | PubTator, text mining | PubMed |
| Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma. | Eur J Endocrinol | 2022 | 35333737 | PubTator, text mining | PubMed |
| Protein interaction networks provide insight into fetal origins of chronic obstructive pulmonary disease. | Respir Res | 2022 | 35331221 | PubTator, text mining | PubMed |
| The Challenge and Opportunity of NTRK Inhibitors in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2022 | 35328336 | PubTator, text mining | PubMed |
| Analytic and Clinical Validation of a Pan-Cancer NGS Liquid Biopsy Test for the Detection of Copy Number Amplifications, Fusions and Exon Skipping Variants. | Diagnostics (Basel) | 2022 | 35328282 | PubTator, text mining | PubMed |
| Detection of NTRK Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort. | Diagnostics (Basel) | 2022 | 35328221 | PubTator, text mining | PubMed |
| Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer. | Cells | 2022 | 35326424 | PubTator, text mining | PubMed |
| Data-Independent Acquisition Enables Robust Quantification of 400 Proteins in Non-Depleted Canine Plasma. | Proteomes | 2022 | 35324581 | PubTator, text mining | PubMed |
| Comprehensive evaluation of the test for 5'-/3'-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer. | Cancer Med | 2022 | 35322575 | PubTator, text mining | PubMed |
| Inflammatory Myofibroblastic Tumor of the Urinary Bladder: An 11-Year Retrospective Study From a Single Center. | Front Med (Lausanne) | 2022 | 35308527 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Seipin collaborates with the ER membrane to control the sites of lipid droplet formation. | Curr Opin Cell Biol | 2022 | 35306312 | PubTator, text mining | PubMed |
| Structural basis for recognition and transport of folic acid in mammalian cells. | Curr Opin Struct Biol | 2022 | 35303537 | PubTator, text mining | PubMed |
| Activation mechanism of the class D fungal GPCR dimer Ste2. | Nature | 2022 | 35296853 | PubTator, text mining | PubMed |
| NTRK Fusions Detection in Paediatric Sarcomas to Expand the Morphological Spectrum and Clinical Relevance of Selected Entities. | Pathol Oncol Res | 2022 | 35295613 | PubTator, text mining | PubMed |
| Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors. | PLoS One | 2022 | 35294956 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers?page=41